Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Modulation of Agrin and RhoA Pathways Ameliorates Movement Defects and Synapse Morphology in MYO9A-Depleted Zebrafish.

O'Connor E, Cairns G, Spendiff S, Burns D, Hettwer S, Mäder A, Müller J, Horvath R, Slater C, Roos A, Lochmüller H.

Cells. 2019 Aug 7;8(8). pii: E848. doi: 10.3390/cells8080848.

2.

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.

McMacken GM, Spendiff S, Whittaker RG, O'Connor E, Howarth RM, Boczonadi V, Horvath R, Slater CR, Lochmüller H.

Hum Mol Genet. 2019 Jul 15;28(14):2339-2351. doi: 10.1093/hmg/ddz059.

3.

'Fragmentation' of NMJs: a sign of degeneration or regeneration? A long journey with many junctions.

Slater CR.

Neuroscience. 2019 May 23. pii: S0306-4522(19)30333-1. doi: 10.1016/j.neuroscience.2019.05.017. [Epub ahead of print]

PMID:
31129203
4.

GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice.

Issop Y, Hathazi D, Khan MM, Rudolf R, Weis J, Spendiff S, Slater CR, Roos A, Lochmüller H.

Hum Mol Genet. 2018 Sep 15;27(18):3218-3232. doi: 10.1093/hmg/ddy225.

5.

Age-related changes in the structure and function of mammalian neuromuscular junctions.

Willadt S, Nash M, Slater C.

Ann N Y Acad Sci. 2018 Jan;1412(1):41-53. doi: 10.1111/nyas.13521. Epub 2017 Dec 31. Review.

PMID:
29291259
6.

Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions.

Nicole S, Azuma Y, Bauché S, Eymard B, Lochmüller H, Slater C.

J Neuromuscul Dis. 2017;4(4):269-284. doi: 10.3233/JND-170257. Review.

7.

The Structure of Human Neuromuscular Junctions: Some Unanswered Molecular Questions.

Slater CR.

Int J Mol Sci. 2017 Oct 19;18(10). pii: E2183. doi: 10.3390/ijms18102183. Review.

8.
9.

The functional organization of motor nerve terminals.

Slater CR.

Prog Neurobiol. 2015 Nov;134:55-103. doi: 10.1016/j.pneurobio.2015.09.004. Epub 2015 Oct 9. Review.

PMID:
26439950
10.

Glutamatergic modulation of synaptic-like vesicle recycling in mechanosensory lanceolate nerve terminals of mammalian hair follicles.

Banks RW, Cahusac PM, Graca A, Kain N, Shenton F, Singh P, Njå A, Simon A, Watson S, Slater CR, Bewick GS.

J Physiol. 2013 May 15;591(10):2523-40. doi: 10.1113/jphysiol.2012.243659. Epub 2013 Feb 25.

11.

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.

Belaya K, Finlayson S, Slater CR, Cossins J, Liu WW, Maxwell S, McGowan SJ, Maslau S, Twigg SR, Walls TJ, Pascual Pascual SI, Palace J, Beeson D.

Am J Hum Genet. 2012 Jul 13;91(1):193-201. doi: 10.1016/j.ajhg.2012.05.022. Epub 2012 Jun 27.

12.

Diverse aspects of vulnerability at the neuromuscular junction.

Slater C.

Brain. 2012 Apr;135(Pt 4):997-8. doi: 10.1093/brain/aws057. Epub 2012 Mar 6. No abstract available.

PMID:
22396396
13.

Reliability of neuromuscular transmission and how it is maintained.

Slater CR.

Handb Clin Neurol. 2008;91:27-101. doi: 10.1016/S0072-9752(07)01502-3. Review. No abstract available.

PMID:
18631840
14.

Congenital myasthenic syndromes and the formation of the neuromuscular junction.

Beeson D, Webster R, Cossins J, Lashley D, Spearman H, Maxwell S, Slater CR, Newsom-Davis J, Palace J, Vincent A.

Ann N Y Acad Sci. 2008;1132:99-103. doi: 10.1196/annals.1405.049.

PMID:
18567858
15.

Structural factors influencing the efficacy of neuromuscular transmission.

Slater CR.

Ann N Y Acad Sci. 2008;1132:1-12. Epub 2007 Dec 20.

PMID:
18096848
16.

Dok-7 mutations underlie a neuromuscular junction synaptopathy.

Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, Newsom-Davis J, Burke G, Fawcett P, Motomura M, Müller JS, Lochmüller H, Slater C, Vincent A, Yamanashi Y.

Science. 2006 Sep 29;313(5795):1975-8. Epub 2006 Aug 17.

17.

Accumulation of Nav1 mRNAs at differentiating postsynaptic sites in rat soleus muscles.

Stocksley MA, Awad SS, Young C, Lightowlers RN, Brenner HR, Slater CR.

Mol Cell Neurosci. 2005 Apr;28(4):694-702.

PMID:
15797716
18.
19.

Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.

Beeson D, Webster R, Ealing J, Croxen R, Brownlow S, Brydson M, Newsom-Davis J, Slater C, Hatton C, Shelley C, Colquhoun D, Vincent A.

Ann N Y Acad Sci. 2003 Sep;998:114-24.

PMID:
14592868

Supplemental Content

Loading ...
Support Center